World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
81
Citations
39262
World Ranking
950
National Ranking
505

Yibin Kang publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Yibin Kang sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 168 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Yibin Kang D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Yibin Kang sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2016 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Yibin Kang is affiliated with Princeton University in the United States. Their research spans multiple areas in medicine and biochemistry, genetics, and molecular biology, with a particular emphasis on molecular biology and oncology. Their work focuses extensively on cancer research, pathology and forensic medicine, and immunology.

The main topics explored in their scholarly work include:

  • Cancer Cells and Metastasis
  • Cancer Mechanisms and Therapy
  • Peptidase Inhibition and Analysis
  • Epigenetics and DNA Methylation
  • Cancer, Hypoxia, and Metabolism
  • Cancer Immunotherapy and Biomarkers
  • Ubiquitin and Proteasome Pathways

Kang has contributed numerous papers published in various outlets, with frequent publications in the following venues:

  • Cancer Research
  • Nature Cancer
  • Genes & Development
  • Nature Communications
  • Nature Reviews Molecular Cell Biology

Notable recent publications include:

  • "Guidelines and definitions for research on epithelial-mesenchymal transition" (2020), Nature Reviews Molecular Cell Biology
  • "Slow TCA flux and ATP production in primary solid tumours but not metastases" (2023), Nature
  • "Emerging strategies for treating metastasis" (2021), Nature Cancer
  • "TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis" (2021), Nature Cell Biology
  • "Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2" (2020), Genes & Development

Frequent collaborators in their research include Yong Wei, Minhong Shen, Xiang Hang, Mark Esposito, and Yujiao Han, reflecting recurring partnerships in cancer and molecular biology studies.

Kang's scientific contributions also received recognition from professional organizations. In 2016, they were named a Fellow of the American Association for the Advancement of Science (AAAS).

Best Publications

  • Tumour exosome integrins determine organotropic metastasis

    Ayuko Hoshino;Bruno Costa-Silva;Tang-Long Shen;Goncalo Rodrigues

  • Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

    Héctor Peinado;Maša Alečković;Simon Lavotshkin;Irina Matei

  • A multigenic program mediating breast cancer metastasis to bone.

    Yibin Kang;Peter M. Siegel;Weiping Shu;Maria Drobnjak

  • The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.

    Manav Korpal;Esther S. Lee;Guohong Hu;Yibin Kang

  • Epithelial-mesenchymal transitions: twist in development and metastasis.

    Yibin Kang;Joan Massagué

  • Pre-metastatic niches: organ-specific homes for metastases

    Héctor Peinado;Haiying Zhang;Irina R. Matei;Bruno Costa-Silva

  • Guidelines and definitions for research on epithelial–mesenchymal transition

    Jing Yang;Parker Antin;Geert Berx;Cédric Blanpain

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

    Ayuko Hoshino;Ayuko Hoshino;Han Sang Kim;Han Sang Kim;Linda Bojmar;Linda Bojmar;Linda Bojmar;Kofi Ennu Gyan

  • Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors

    Andy J. Minn;Yibin Kang;Inna Serganova;Gaorav P. Gupta

  • Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis

    Wei Lu;Yibin Kang

  • Beyond tumorigenesis: cancer stem cells in metastasis.

    Feng Li;Benjamin Tiede;Joan Massagué;Yibin Kang

  • Tumor metastasis: moving new biological insights into the clinic

    Liling Wan;Klaus Pantel;Yibin Kang

  • Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis

    Xin Lu;Yibin Kang;Yibin Kang

  • A Self-Enabling TGFβ Response Coupled to Stress Signaling: Smad Engages Stress Response Factor ATF3 for Id1 Repression in Epithelial Cells

    Yibin Kang;Chang Rung Chen;Joan Massagué

  • Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization

    Manav Korpal;Brian J Ell;Francesca M Buffa;Toni Ibrahim

  • Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway

    Yibin Kang;Wei He;Shaun Tulley;Gaorav P. Gupta

  • Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells

    Nilay Sethi;Xudong Dai;Christopher G. Winter;Yibin Kang

  • E2F4/5 and p107 as Smad Cofactors Linking the TGFβ Receptor to c-myc Repression

    Chang Rung Chen;Yibin Kang;Peter M. Siegel;Joan Massagué

  • VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors

    Xin Lu;Euphemia Mu;Yong Wei;Sabine Riethdorf

  • Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients

    Yibin Kang;Klaus Pantel

Frequent Co-Authors

Joan Massagué
Joan Massagué Memorial Sloan Kettering Cancer Center
Bryan R. Cullen
Bryan R. Cullen Duke University
Dino Amadori
Dino Amadori University of Bologna
Benjamin A. Garcia
Benjamin A. Garcia Washington University in St. Louis
Klaus Pantel
Klaus Pantel Universität Hamburg
Fadlo R. Khuri
Fadlo R. Khuri American University of Beirut
David Lyden
David Lyden Cornell University
Gary LeRoy
Gary LeRoy New York University
Joshua D. Rabinowitz
Joshua D. Rabinowitz Princeton University
Bruce G. Haffty
Bruce G. Haffty Rutgers, The State University of New Jersey

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Many students exploring medicine in the USA also consider alternative pathways and complementary healthcare degrees, especially with the rise of flexible online education options. These programs offer a faster or more affordable route to diverse roles in the medical field.

For those looking to enter the nursing profession quickly, accelerated lpn programs offer a streamlined way to earn a practical nursing credential online. Students interested in mental health care can pursue psych np programs, which provide specialized psychiatric nurse practitioner training for advanced roles.

If your interests lie in healthcare leadership rather than direct patient care, pursuing a healthcare administration degree online is a popular choice. For graduate-level leadership opportunities, consider cheap mha programs that offer affordability without compromising quality.

These flexible online degrees open up numerous career pathways—whether your aim is clinical practice, mental health, or healthcare management—making them excellent options to consider alongside studying traditional medicine.

Best Scientists Citing Yibin Kang

Trending Scientists

Recently Published Articles